Eva Malikova
Bratislava, BL 83232, Slovakia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Navigating the orphan medicinal product designation: Evidence requirements for gene therapies in Europe.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 30, 2024
Advancing rare disease treatment: EMA's decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation.
Journal: Gene therapy
Published: December 01, 2023
The European landscape for gene therapies in orphan diseases: 6-year experience with the EMA Committee for Orphan Medicinal Products.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 25, 2023
Licensing of Orphan Medicinal Products-Use of Real-World Data and Other External Data on Efficacy Aspects in Marketing Authorization Applications Concluded at the European Medicines Agency Between 2019 and 2021.
Journal: Frontiers in pharmacology
Published: April 14, 2022
Pioglitazone restores phosphorylation of downregulated caveolin-1 in right ventricle of monocrotaline-induced pulmonary hypertension.
Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)
Published: November 08, 2021
Availability and Accessibility of Orphan Medicinal Products to Patients in Slovakia in the Years 2010-2019.
Journal: Frontiers in pharmacology
Published: August 31, 2021
Defining Satisfactory Methods of Treatment in Rare Diseases When Evaluating Significant Benefit-The EU Regulator's Perspective.
Journal: Frontiers in medicine
Published: July 20, 2021
Altered serum levels of neprilysin in heart failure patients with reduced ejection fraction.
Journal: Bratislavske lekarske listy
Published: January 04, 2021
Disease severity-related alterations of cardiac microRNAs in experimental pulmonary hypertension.
Journal: Journal of cellular and molecular medicine
Published: February 10, 2020
Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases.
Journal: Drug discovery today
Published: July 26, 2019
Effects of inorganic nitrate in a rat model of monocrotaline-induced pulmonary arterial hypertension.
Journal: Basic & clinical pharmacology & toxicology
Published: June 11, 2019
Opposite alterations of endothelin-1 in lung and pulmonary artery mirror gene expression of bone morphogenetic protein receptor 2 in experimental pulmonary hypertension.
Journal: Experimental lung research
Published: April 24, 2019
Last Updated: 09/26/2026